A Non-Invasive Blood-Based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years
This new study demonstrates that a blood test used with imaging can improve breast cancer detection and substantially reduce the use of potentially unnecessary biopsies.
In cancer, nothing is more important than early and accurate diagnosis
Women under the age of 50 are likely to have difficult-to-interpret breasts, with a high rate of breast density
There is a need for additional tools to detect breast cancer and reduce potentially avoidable biopsy
Despite significant advances in breast imaging, the ability to detect breast cancer (BC) remains a challenge. To address the unmet needs of the current BC detection paradigm, two prospective clinical trials were conducted to develop a blood-based Combinatorial Proteomic Biomarker Assay (Videssa® Breast) to accurately detect BC and reduce false positives (FP) from suspicious imaging findings.
Learn more by downloading the publication from Clincal Breast Cancer journal